Q97760121

Summary

Q97760121 is an individual motion^[1].

Key Facts

• Q97760121 authored Markus Wiechel^[2].
• Q97760121 authored Johan Nissinen^[3].
• Q97760121 authored Linus Bylund^[4].
• Q97760121 authored Jeff Ahl^[5].
• Q97760121 authored Jennie Åfeldt^[6].
• Q97760121's instance of is recorded as individual motion^[7].
• Q97760121's part of the series is recorded as motions of 2016-2017 legislative session of the Riksdag^[8].
• Q97760121's language of work or name is recorded as Swedish^[9].
• Q97760121 was published on +2016-10-05T00:00:00Z^[10].
• Q97760121's main subject is medication^[11].
• Q97760121's work available at URL is recorded as http://data.riksdagen.se/dokument/H4022892^[12].
• Q97760121's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H4022892^[13].
• Q97760121's applies to jurisdiction is recorded as Sweden^[14].
• Q97760121's legal citation of this text is recorded as Mot. 2016/17:2892^[15].
• Q97760121's title is recorded as Nya läkemedelsalternativ för svårt sjuka^[16].
• Q97760121's maintained by WikiProject is recorded as Project Riksdagen's documents^[17].
• Q97760121's copyright status is recorded as public domain^[18].
• Q97760121's legislative committee is recorded as Committee on Health and Welfare^[19].

Body

Definition and Type

Q97760121's instance of is recorded as individual motion^[7].